Mesa Laboratories, Inc.
Mesa Laboratories develops, manufactures, sells, and services life sciences tools and quality control products. The Sterilization and Disinfection Control segment offers indicators for assessing sterilization decontamination, disinfection, and cleaning processes. This segment also provides testing and laboratory services to dental and pharmaceutical industries. The Clinical Genomics segment offers genetic analysis tool systems, including MassARRAY and consumables. The Biopharmaceutical Development segment provides automated systems, instruments, and kits for protein analysis and peptide synthesis. The Calibration Solutions segment offers quality control products for measuring critical parameters in various applications.
Overview
Sector
Scientific Instruments
Strengths
- Asset-light, cash-generative model: capital expenditure takes only 1.7% of revenue and free cash flow was positive in each of the last 7 years.
- Valued below its Scientific & Technical Instruments peers: P/FCF 16.7x vs. a median of 28.2x.
- Consistent growth: revenue has compounded at 13.3% a year over 6 years, rising in 5 of them.
- Improving fundamentals over the last year: return on assets up 2.0 points, gross margin up 0.9 points and asset turnover up 4.7%.
- Cheaper than its own history: P/FCF 16.7x vs. a historical average of 30.5x.
Weaknesses
- Heavy interest burden: interest expense absorbs 47% of operating profit.
- Our discounted cash flow target price (53.70 USD) is 55% below the current price.
- Valued at a premium to its Scientific & Technical Instruments peers: P/E 98.2x vs. a median of 35.5x.
- Earnings are projected to decline (-10.0% per year).
Key Financial Data